CTT PHARMACEUTICAL HOLDINGS, INC. purchased $590 of CTTH
CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 10,000 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.06 on 2026-08-19.
How this was made
The 30-second read
Why it matters
The transaction is too small to affect market perception significantly.
Market read
Routine insider buy with minimal trading relevance.
What to watch
The CEO's large existing stake may make this purchase routine rather than indicative.
Background
Form 4 filing discloses insider transactions; this is the first public report of the purchase.
Ticker impact
CEO purchased 10,000 shares for $590 via open-market transaction filed today.
No material price impact expected.
Purchase amount is tiny relative to holdings and market cap; unlikely to move price.
Market effects
None
None
None
Counterpoint
Insider purchase could be a subtle signal of upcoming positive news.
Key entities
- CompanyCTT Pharmaceutical Holdings, Inc.
Biopharmaceutical company filing the insider transaction.
- PersonCEO (unnamed)
Insider executing the purchase.